These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24105672)

  • 1. Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.
    Jones D; Vichaya EG; Wang XS; Sailors MH; Cleeland CS; Wefel JS
    Cancer; 2013 Dec; 119(23):4188-95. PubMed ID: 24105672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Course of cognitive decline in hematopoietic stem cell transplantation: a within-subjects design.
    Friedman MA; Fernandez M; Wefel JS; Myszka KA; Champlin RE; Meyers CA
    Arch Clin Neuropsychol; 2009 Nov; 24(7):689-98. PubMed ID: 19767298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive functioning in allogeneic hematopoietic stem cell transplantation recipients and its medical correlates: a prospective multicenter study.
    Scherwath A; Schirmer L; Kruse M; Ernst G; Eder M; Dinkel A; Kunze S; Balck F; Bornhäuser M; Ehninger G; Dolan K; Gramatzki M; Kolb HJ; Heußner P; Wilhelm H; Beelen DW; Schulz-Kindermann F; Zander AR; Koch U; Mehnert A
    Psychooncology; 2013 Jul; 22(7):1509-16. PubMed ID: 22945857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in cognitive functioning in the year after hematopoietic stem cell transplantation.
    Jacobs SR; Small BJ; Booth-Jones M; Jacobsen PB; Fields KK
    Cancer; 2007 Oct; 110(7):1560-7. PubMed ID: 17685391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive Functioning After Hematopoietic Cell Transplantation for Hematologic Malignancy: Results From a Prospective Longitudinal Study.
    Sharafeldin N; Bosworth A; Patel SK; Chen Y; Morse E; Mather M; Sun C; Francisco L; Forman SJ; Wong FL; Bhatia S
    J Clin Oncol; 2018 Feb; 36(5):463-475. PubMed ID: 29252122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation.
    Mayo SJ; Messner HA; Rourke SB; Howell D; Victor JC; Lipton JH; Kuruvilla J; Gutpa V; Kim DDH; Michelis FV; Metcalfe K
    Bone Marrow Transplant; 2020 May; 55(5):918-928. PubMed ID: 31745248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample-The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study.
    Wauben B; van der Poel MWM; Greevenbroek MMJ; van Yperen NC; Schram MT; van Boxtel MPJ; Sastry M; Simons SO; Stehouwer CDA; Dagnelie PC; Wesselius A; Schouten HC; Köhler S
    Transplant Cell Ther; 2023 Jul; 29(7):468.e1-468.e8. PubMed ID: 36966872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.
    Huang SY; Lin HH; Lin CW; Li CC; Yao M; Tang JL; Hou HA; Tsay W; Chou SJ; Cheng CL; Tien HF
    Oncotarget; 2016 Sep; 7(38):62490-62502. PubMed ID: 27566569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive changes associated with switching to frequent nocturnal hemodialysis or renal transplantation.
    Dixon BS; VanBuren JM; Rodrigue JR; Lockridge RS; Lindsay R; Chan C; Rocco MV; Oleson JJ; Beglinger L; Duff K; Paulsen JS; Stokes JB;
    BMC Nephrol; 2016 Jan; 17():12. PubMed ID: 26801094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study.
    Cavo M; Gay F; Beksac M; Pantani L; Petrucci MT; Dimopoulos MA; Dozza L; van der Holt B; Zweegman S; Oliva S; van der Velden VHJ; Zamagni E; Palumbo GA; Patriarca F; Montefusco V; Galli M; Maisnar V; Gamberi B; Hansson M; Belotti A; Pour L; Ypma P; Grasso M; Croockewit A; Ballanti S; Offidani M; Vincelli ID; Zambello R; Liberati AM; Andersen NF; Broijl A; Troia R; Pascarella A; Benevolo G; Levin MD; Bos G; Ludwig H; Aquino S; Morelli AM; Wu KL; Boersma R; Hajek R; Durian M; von dem Borne PA; Caravita di Toritto T; Zander T; Driessen C; Specchia G; Waage A; Gimsing P; Mellqvist UH; van Marwijk Kooy M; Minnema M; Mandigers C; Cafro AM; Palmas A; Carvalho S; Spencer A; Boccadoro M; Sonneveld P
    Lancet Haematol; 2020 Jun; 7(6):e456-e468. PubMed ID: 32359506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of cognitive decline after chemotherapy in breast cancer patients.
    Vearncombe KJ; Rolfe M; Wright M; Pachana NA; Andrew B; Beadle G
    J Int Neuropsychol Soc; 2009 Nov; 15(6):951-62. PubMed ID: 19709455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal cognitive assessment in patients with primary CNS lymphoma treated with induction chemotherapy followed by reduced-dose whole-brain radiotherapy or autologous stem cell transplantation.
    Correa DD; Braun E; Kryza-Lacombe M; Ho KW; Reiner AS; Panageas KS; Yahalom J; Sauter CS; Abrey LE; DeAngelis LM; Omuro A
    J Neurooncol; 2019 Sep; 144(3):553-562. PubMed ID: 31377920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation.
    Toro JJ; Gushiken FC; Schneider D; Lee S; Haile DJ; Freytes CO
    Support Care Cancer; 2016 Aug; 24(8):3411-5. PubMed ID: 26984247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical predictors of cognitive function in adults treated with hematopoietic cell transplantation.
    Jim HS; Small B; Hartman S; Franzen J; Millay S; Phillips K; Jacobsen PB; Booth-Jones M; Pidala J
    Cancer; 2012 Jul; 118(13):3407-16. PubMed ID: 22139882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
    Świerzko AS; Michalski M; Sokołowska A; Nowicki M; Eppa Ł; Szala-Poździej A; Mitrus I; Szmigielska-Kapłon A; Sobczyk-Kruszelnicka M; Michalak K; Gołos A; Wierzbowska A; Giebel S; Jamroziak K; Kowalski ML; Brzezińska O; Thiel S; Jensenius JC; Kasperkiewicz K; Cedzyński M
    Front Immunol; 2018; 9():2153. PubMed ID: 30294330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lobar microbleeds are associated with a decline in executive functioning in older adults.
    Meier IB; Gu Y; Guzaman VA; Wiegman AF; Schupf N; Manly JJ; Luchsinger JA; Viswanathan A; Martinez-Ramirez S; Greenberg SM; Mayeux R; Brickman AM
    Cerebrovasc Dis; 2014; 38(5):377-83. PubMed ID: 25427958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
    Tosi P; Zamagni E; Ronconi S; Benni M; Motta MR; Rizzi S; Tura S; Cavo M
    Leukemia; 2000 Jul; 14(7):1310-3. PubMed ID: 10914557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failure].
    Firsova MV; Mendeleeva LP; Solovev MV; Rekhtina IG; Pokrovskaya OS; Urnova ES; Soboleva NP; Dvirnyk VN; Klyasova GA; Kuzmina LA; Savchenko VG
    Ter Arkh; 2020 Sep; 92(7):70-76. PubMed ID: 33346447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microembolization is associated with transient cognitive decline in patients undergoing carotid interventions.
    Hitchner E; Baughman BD; Soman S; Long B; Rosen A; Zhou W
    J Vasc Surg; 2016 Dec; 64(6):1719-1725. PubMed ID: 27633169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive complaints by hematopoietic cell transplantation recipients and change in neuropsychological performance over time.
    LaLonde L; Votruba K; Kentor R; Gatza E; Choi SW; Hoodin F
    Support Care Cancer; 2021 Jan; 29(1):247-254. PubMed ID: 32346799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.